Status:
COMPLETED
Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
The Royal Norwegian Ministry of Health
Conditions:
Neoplasm Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR...
Eligibility Criteria
Inclusion
- brain metastases
Exclusion
- children
- pregnancy
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00184353
Start Date
November 1 2003
End Date
June 1 2005
Last Update
October 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwegian University of Science and Technology
Trondheim, Norway, N-7489